IBDEI0C8 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16539,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,16539,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,16540,0)
 ;;=250.60^^107^1074^28
 ;;^UTILITY(U,$J,358.3,16540,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16540,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,16540,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,16540,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,16541,0)
 ;;=356.9^^107^1074^30
 ;;^UTILITY(U,$J,358.3,16541,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16541,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,16541,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,16541,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,16542,0)
 ;;=780.2^^107^1074^38
 ;;^UTILITY(U,$J,358.3,16542,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16542,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,16542,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,16542,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,16543,0)
 ;;=724.3^^107^1074^34
 ;;^UTILITY(U,$J,358.3,16543,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16543,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,16543,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,16543,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,16544,0)
 ;;=780.39^^107^1074^36
 ;;^UTILITY(U,$J,358.3,16544,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16544,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,16544,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,16544,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,16545,0)
 ;;=782.0^^107^1074^26
 ;;^UTILITY(U,$J,358.3,16545,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16545,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,16545,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,16545,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,16546,0)
 ;;=435.9^^107^1074^40
 ;;^UTILITY(U,$J,358.3,16546,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16546,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,16546,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,16546,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,16547,0)
 ;;=354.2^^107^1074^42
 ;;^UTILITY(U,$J,358.3,16547,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16547,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,16547,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,16547,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,16548,0)
 ;;=729.1^^107^1074^18
 ;;^UTILITY(U,$J,358.3,16548,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16548,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,16548,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,16548,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,16549,0)
 ;;=438.20^^107^1074^7
 ;;^UTILITY(U,$J,358.3,16549,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16549,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,16549,1,5,0)
 ;;=5^CVA with Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,16549,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,16550,0)
 ;;=438.12^^107^1074^6
 ;;^UTILITY(U,$J,358.3,16550,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16550,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,16550,1,5,0)
 ;;=5^CVA with Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,16550,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,16551,0)
 ;;=356.8^^107^1074^29
 ;;^UTILITY(U,$J,358.3,16551,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16551,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,16551,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,16551,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,16552,0)
 ;;=337.20^^107^1074^32
 ;;^UTILITY(U,$J,358.3,16552,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16552,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,16552,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,16552,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,16553,0)
 ;;=294.8^^107^1074^15
 ;;^UTILITY(U,$J,358.3,16553,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16553,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,16553,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,16553,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,16554,0)
 ;;=438.6^^107^1074^4
 ;;^UTILITY(U,$J,358.3,16554,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16554,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,16554,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,16554,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,16555,0)
 ;;=438.7^^107^1074^5
 ;;^UTILITY(U,$J,358.3,16555,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16555,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,16555,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,16555,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,16556,0)
 ;;=438.84^^107^1074^3
 ;;^UTILITY(U,$J,358.3,16556,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16556,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,16556,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,16556,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,16557,0)
 ;;=434.91^^107^1074^8
 ;;^UTILITY(U,$J,358.3,16557,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16557,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,16557,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,16557,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,16558,0)
 ;;=333.94^^107^1074^33
 ;;^UTILITY(U,$J,358.3,16558,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16558,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,16558,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,16558,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,16559,0)
 ;;=345.90^^107^1074^35
 ;;^UTILITY(U,$J,358.3,16559,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16559,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,16559,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,16559,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,16560,0)
 ;;=305.01^^107^1075^10
 ;;^UTILITY(U,$J,358.3,16560,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16560,1,4,0)
 ;;=4^305.01
 ;;^UTILITY(U,$J,358.3,16560,1,5,0)
 ;;=5^Etoh Abuse-Continuous
 ;;^UTILITY(U,$J,358.3,16560,2)
 ;;=^268228
 ;;^UTILITY(U,$J,358.3,16561,0)
 ;;=305.02^^107^1075^1
 ;;^UTILITY(U,$J,358.3,16561,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16561,1,4,0)
 ;;=4^305.02
 ;;^UTILITY(U,$J,358.3,16561,1,5,0)
 ;;=5^Alcohol Abuse-Episodic
 ;;^UTILITY(U,$J,358.3,16561,2)
 ;;=^268229
 ;;^UTILITY(U,$J,358.3,16562,0)
 ;;=305.03^^107^1075^2
 ;;^UTILITY(U,$J,358.3,16562,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16562,1,4,0)
 ;;=4^305.03
 ;;^UTILITY(U,$J,358.3,16562,1,5,0)
 ;;=5^Alcohol Abuse-In Remiss
 ;;^UTILITY(U,$J,358.3,16562,2)
 ;;=^268230
 ;;^UTILITY(U,$J,358.3,16563,0)
 ;;=303.90^^107^1075^11
 ;;^UTILITY(U,$J,358.3,16563,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16563,1,4,0)
 ;;=4^303.90
 ;;^UTILITY(U,$J,358.3,16563,1,5,0)
 ;;=5^Etoh Dependence
 ;;^UTILITY(U,$J,358.3,16563,2)
 ;;=^268187
 ;;^UTILITY(U,$J,358.3,16564,0)
 ;;=300.00^^107^1075^3
 ;;^UTILITY(U,$J,358.3,16564,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16564,1,4,0)
 ;;=4^300.00
 ;;^UTILITY(U,$J,358.3,16564,1,5,0)
 ;;=5^Anxiety
 ;;^UTILITY(U,$J,358.3,16564,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,16565,0)
 ;;=296.7^^107^1075^4
 ;;^UTILITY(U,$J,358.3,16565,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16565,1,4,0)
 ;;=4^296.7
 ;;^UTILITY(U,$J,358.3,16565,1,5,0)
 ;;=5^Bipolar Affective Disorder
 ;;^UTILITY(U,$J,358.3,16565,2)
 ;;=^14793
 ;;^UTILITY(U,$J,358.3,16566,0)
 ;;=304.20^^107^1075^5
 ;;^UTILITY(U,$J,358.3,16566,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16566,1,4,0)
 ;;=4^304.20
 ;;^UTILITY(U,$J,358.3,16566,1,5,0)
 ;;=5^Cocaine Dependence
 ;;^UTILITY(U,$J,358.3,16566,2)
 ;;=^25599
 ;;^UTILITY(U,$J,358.3,16567,0)
 ;;=294.11^^107^1075^6
 ;;^UTILITY(U,$J,358.3,16567,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16567,1,4,0)
 ;;=4^294.11
 ;;^UTILITY(U,$J,358.3,16567,1,5,0)
 ;;=5^Dementia W/Behav Disturb
 ;;^UTILITY(U,$J,358.3,16567,2)
 ;;=^321982
 ;;^UTILITY(U,$J,358.3,16568,0)
 ;;=294.10^^107^1075^7
 ;;^UTILITY(U,$J,358.3,16568,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16568,1,4,0)
 ;;=4^294.10
 ;;^UTILITY(U,$J,358.3,16568,1,5,0)
 ;;=5^Dementia W/O Behav Disturb
 ;;^UTILITY(U,$J,358.3,16568,2)
 ;;=^321980
 ;;^UTILITY(U,$J,358.3,16569,0)
 ;;=311.^^107^1075^8
 ;;^UTILITY(U,$J,358.3,16569,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16569,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,16569,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,16569,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,16570,0)
 ;;=309.0^^107^1075^9
 ;;^UTILITY(U,$J,358.3,16570,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16570,1,4,0)
 ;;=4^309.0
 ;;^UTILITY(U,$J,358.3,16570,1,5,0)
 ;;=5^Depressive Reaction, Brief
 ;;^UTILITY(U,$J,358.3,16570,2)
 ;;=^3308
 ;;^UTILITY(U,$J,358.3,16571,0)
 ;;=305.50^^107^1075^12
 ;;^UTILITY(U,$J,358.3,16571,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16571,1,4,0)
 ;;=4^305.50
 ;;^UTILITY(U,$J,358.3,16571,1,5,0)
 ;;=5^IV Drug Use
 ;;^UTILITY(U,$J,358.3,16571,2)
 ;;=^85868
 ;;^UTILITY(U,$J,358.3,16572,0)
 ;;=302.72^^107^1075^13
 ;;^UTILITY(U,$J,358.3,16572,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16572,1,4,0)
 ;;=4^302.72
 ;;^UTILITY(U,$J,358.3,16572,1,5,0)
 ;;=5^Inhibited Sex Excitement(Not Organic Impotence)
 ;;^UTILITY(U,$J,358.3,16572,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,16573,0)
 ;;=780.52^^107^1075^14
 ;;^UTILITY(U,$J,358.3,16573,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16573,1,4,0)
 ;;=4^780.52
 ;;^UTILITY(U,$J,358.3,16573,1,5,0)
 ;;=5^Insomnia
 ;;^UTILITY(U,$J,358.3,16573,2)
 ;;=^87662
 ;;^UTILITY(U,$J,358.3,16574,0)
 ;;=300.3^^107^1075^15
 ;;^UTILITY(U,$J,358.3,16574,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16574,1,4,0)
 ;;=4^300.3
 ;;^UTILITY(U,$J,358.3,16574,1,5,0)
 ;;=5^Obsessive-Compulsive
 ;;^UTILITY(U,$J,358.3,16574,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,16575,0)
 ;;=304.00^^107^1075^16
 ;;^UTILITY(U,$J,358.3,16575,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16575,1,4,0)
 ;;=4^304.00
 ;;^UTILITY(U,$J,358.3,16575,1,5,0)
 ;;=5^Opioid Dependence 
 ;;^UTILITY(U,$J,358.3,16575,2)
 ;;=^81364
